These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 38165674)
1. Transition to Oral Antibiotic Therapy for Hospitalized Adults With Gram-Negative Bloodstream Infections. Engers DW; Tamma PD; Fiawoo S; Fong K; Jariwala R; Jenkins TC; Kendall RE; Lee JH; McCreary EK; Patel PK; Shihadeh KC; Slish J; Van Schooneveld TC; Malani AN JAMA Netw Open; 2024 Jan; 7(1):e2349864. PubMed ID: 38165674 [TBL] [Abstract][Full Text] [Related]
2. Oral β-Lactam Antibiotics vs Fluoroquinolones or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Enterobacterales Bacteremia From a Urine Source. Sutton JD; Stevens VW; Chang NN; Khader K; Timbrook TT; Spivak ES JAMA Netw Open; 2020 Oct; 3(10):e2020166. PubMed ID: 33030555 [TBL] [Abstract][Full Text] [Related]
3. Empirical fluoroquinolones versus broad-spectrum beta-lactams for Gram-negative bloodstream infections in the absence of antimicrobial resistance risk factors. Al-Hasan MN; Gould AP; Drennan C; Hill O; Justo JA; Kohn J; Bookstaver PB J Glob Antimicrob Resist; 2020 Sep; 22():87-93. PubMed ID: 31887412 [TBL] [Abstract][Full Text] [Related]
4. Association of 30-Day Mortality With Oral Step-Down vs Continued Intravenous Therapy in Patients Hospitalized With Enterobacteriaceae Bacteremia. Tamma PD; Conley AT; Cosgrove SE; Harris AD; Lautenbach E; Amoah J; Avdic E; Tolomeo P; Wise J; Subudhi S; Han JH; JAMA Intern Med; 2019 Mar; 179(3):316-323. PubMed ID: 30667477 [TBL] [Abstract][Full Text] [Related]
5. Early Switch From Intravenous to Oral Antibiotics for Patients With Uncomplicated Gram-Negative Bacteremia. Tingsgård S; Bastrup Israelsen S; Jørgensen HL; Østergaard C; Benfield T JAMA Netw Open; 2024 Jan; 7(1):e2352314. PubMed ID: 38261322 [TBL] [Abstract][Full Text] [Related]
6. Comparative-Effectiveness of Oral Beta-Lactams and Fluoroquinolones for Stepdown Therapy in Patients with Enterobacterales Bloodstream Infections: A Retrospective Cohort Study. Bjork L; Hopkins T; Yang L; Teng C; Jones X; Cadena J; Walter E; Frei CR Int J Med Sci; 2023; 20(4):437-443. PubMed ID: 37057217 [No Abstract] [Full Text] [Related]
7. Highly versus less bioavailable oral antibiotics in the treatment of gram-negative bloodstream infections: a propensity-matched cohort analysis. Mponponsuo K; Brown KA; Fridman DJ; Johnstone J; Langford BJ; Lee SM; MacFadden DR; Patel SN; Schwartz KL; Daneman N Clin Microbiol Infect; 2023 Apr; 29(4):490-497. PubMed ID: 36216237 [TBL] [Abstract][Full Text] [Related]
8. Intravenous to oral transition of antibiotics for gram-negative bloodstream infection at a University hospital in Thailand: Clinical outcomes and predictors of treatment failure. Pradubkham T; Suwanpimolkul G; Gross AE; Nakaranurack C PLoS One; 2022; 17(9):e0273369. PubMed ID: 36137077 [TBL] [Abstract][Full Text] [Related]
10. Oral β-lactams vs fluoroquinolones and trimethoprim/sulfamethoxazole for step-down therapy for Escherichia coli, Proteus mirabilis, and Klebsiella pneumoniae bacteremia. McAlister MJ; Rose DT; Hudson FP; Padilla-Tolentino E; Jaso TC Am J Health Syst Pharm; 2023 Feb; 80(Suppl 1):S33-S41. PubMed ID: 35868628 [TBL] [Abstract][Full Text] [Related]
11. Impact of Incremental Delays in Appropriate Therapy on the Outcomes of Hospitalized Adult Patients with Gram-negative Bloodstream Infections: "Every day matters". Lodise TP; Kanakamedala H; Hsu WC; Cai B Pharmacotherapy; 2020 Sep; 40(9):889-901. PubMed ID: 33112456 [TBL] [Abstract][Full Text] [Related]
12. Oral antibiotics for the treatment of Gram-negative bloodstream infections: A retrospective comparison of three antibiotic classes. Nisly SA; McClain DL; Fillius AG; Davis KA J Glob Antimicrob Resist; 2020 Mar; 20():74-77. PubMed ID: 31390537 [TBL] [Abstract][Full Text] [Related]
13. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center. Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073 [TBL] [Abstract][Full Text] [Related]
14. A Retrospective Analysis of Intravenous vs Oral Antibiotic Step-Down Therapy for the Treatment of Uncomplicated Streptococcal Bloodstream Infections. Ramos-Otero GP; Sarangarm P; Walraven C J Clin Pharmacol; 2022 Nov; 62(11):1372-1378. PubMed ID: 35661173 [TBL] [Abstract][Full Text] [Related]
15. Variability in oral antibiotic step-down therapy in the management of Gram-negative bloodstream infections. Thaden JT; Tamma PD; Doi Y; Daneman N; Int J Antimicrob Agents; 2021 Dec; 58(6):106451. PubMed ID: 34653617 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of Antibiotic-Resistant Pathogens in Culture-Proven Sepsis and Outcomes Associated With Inadequate and Broad-Spectrum Empiric Antibiotic Use. Rhee C; Kadri SS; Dekker JP; Danner RL; Chen HC; Fram D; Zhang F; Wang R; Klompas M; JAMA Netw Open; 2020 Apr; 3(4):e202899. PubMed ID: 32297949 [TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis comparing oral stepdown therapy for enterobacteriaceae bloodstream infections: fluoroquinolones versus β-lactams. Mercuro NJ; Stogsdill P; Wungwattana M Int J Antimicrob Agents; 2018 May; 51(5):687-692. PubMed ID: 29284155 [TBL] [Abstract][Full Text] [Related]
18. Temporal Trends and Hospital Variation in Time-to-Antibiotics Among Veterans Hospitalized With Sepsis. Wayne MT; Seelye S; Molling D; Wang XQ; Donnelly JP; Hogan CK; Jones MM; Iwashyna TJ; Liu VX; Prescott HC JAMA Netw Open; 2021 Sep; 4(9):e2123950. PubMed ID: 34491351 [TBL] [Abstract][Full Text] [Related]
19. Transition to Oral versus Continued Intravenous Antibiotics for Patients with Pyogenic Liver Abscesses: A Retrospective Analysis. Giangiuli SE; Mueller SW; Jeffres MN Pharmacotherapy; 2019 Jul; 39(7):734-740. PubMed ID: 31148192 [TBL] [Abstract][Full Text] [Related]
20. Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis: the EASI-SWITCH RCT. Coyle V; Forde C; Adams R; Agus A; Barnes R; Chau I; Clarke M; Doran A; Grayson M; McAuley D; McDowell C; Phair G; Plummer R; Storey D; Thomas A; Wilson R; McMullan R Health Technol Assess; 2024 Mar; 28(14):1-101. PubMed ID: 38512064 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]